Sentinel Pension Advisors’s Spero Therapeutics SPRO Stock Holding History

Sentinel Pension Advisors’s Portfolio SPRO Stock Details SPRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,000	Closed	-$20.8K	–	92
2022 Q4	$20.8K	Hold	12,000	–	–	0.01%	85
2022 Q3	$24K	Sell	12,000 -30,000	-71%	-$29.8K	0.01%	83
2022 Q2	$31K	Hold	42,000	–	–	0.01%	88
2022 Q1	$365K	Buy	42,000 +11,800	+39%	+$121K	0.12%	68
2021 Q4	$484K	Buy	30,200 +10,000	+50%	+$159K	0.15%	63
2021 Q3	$372K	Buy	+20,200	New	+$324K	0.13%	67
2021 Q2	–	Sell	-26,410	Closed	-$425K	–	98
2021 Q1	$425K	Buy	26,410 +2,795	+12%	+$49.2K	0.16%	54
2020 Q4	$458K	Buy	+23,615	New	+$368K	0.17%	57

Other funds holding SPRO

Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Murchinson Toronto, Ontario, Canada $249M AUM 68.08% 1-Year Est. Return

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return